| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.26 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |